SARS-CoV-2 Omicron boosting induces de novo B cell response in humans-Reference-Cited by-同舟云学术

SARS-CoV-2 Omicron boosting induces de novo B cell response in humans

Published:2023-04-03 Issue:7961 Volume:617 Page:592-598
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Alsoussi Wafaa B.,Malladi Sameer Kumar^ORCID,Zhou Julian Q.^ORCID,Liu Zhuoming^ORCID,Ying Baoling,Kim Wooseob^ORCID,Schmitz Aaron J.^ORCID,Lei Tingting,Horvath Stephen C.,Sturtz Alexandria J.,McIntire Katherine M.,Evavold Birk,Han Fangjie,Scheaffer Suzanne M.,Fox Isabella F.,Mirza Senaa F.^ORCID,Parra-Rodriguez Luis,Nachbagauer Raffael,Nestorova Biliana,Chalkias Spyros,Farnsworth Christopher W.,Klebert Michael K.,Pusic Iskra,Strnad Benjamin S.^ORCID,Middleton William D.,Teefey Sharlene A.,Whelan Sean P. J.^ORCID,Diamond Michael S.^ORCID,Paris Robert,O’Halloran Jane A.^ORCID,Presti Rachel M.^ORCID,Turner Jackson S.^ORCID,Ellebedy Ali H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-023-06025-4.pdf

Reference65 articles.

1. Krause, P. R. et al. SARS-CoV-2 variants and vaccines. N. Engl. J. Med. 385, 179–186 (2021).

2. Turner, J. S. et al. SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses. Nature 596, 109–113 (2021).

3. Laidlaw, B. J. & Ellebedy, A. H. The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7–18 (2022).

4. Amanat, F. et al. SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 184, 3936–3948.e10 (2021).

5. Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature 607, 128–134 (2022).

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants;Journal of Infection;2024-10

2. Finite immune imprinting on neutralizing antibody responses to Omicron subvariants by repeated vaccinations;International Journal of Infectious Diseases;2024-10

3. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates;Nature Immunology;2024-09-03

4. Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses;Cell Reports;2024-09

5. Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain;Journal of Virology;2024-08-28